Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES

Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Richard S. Geary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosie Z. Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Watanabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott P. Henry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Greg E. Hardee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Chappell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Matson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Sasmor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Len Cummins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur A. Levin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 11 1419-1428
DOI 
https://doi.org/10.1124/dmd.31.11.1419
PubMed 
14570775

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 12, 2003
  • Accepted August 19, 2003
  • Published online October 21, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Richard S. Geary,
  2. Rosie Z. Yu,
  3. Tanya Watanabe,
  4. Scott P. Henry,
  5. Greg E. Hardee,
  6. Alfred Chappell,
  7. John Matson,
  8. Henri Sasmor,
  9. Len Cummins and
  10. Arthur A. Levin
  1. Isis Pharmaceuticals, Carlsbad, California
  1. Address correspondence to:
    Dr. Richard S. Geary, Isis Pharmaceuticals, Inc., 2292 Faraday Avenue, Carlsbad, CA 92008. E-mail: rgeary{at}isisph.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2003 to January 2021

AbstractFullPdf
Oct 2003273026
Nov 2003275019
Dec 2003132326
Jan 2004303918
Feb 200482824
Mar 2004173521
Apr 200410196
May 2004112415
Jun 2004183614
Jul 2004183220
Aug 200425587
Sep 200424277
Oct 200426365
Nov 2004172523
Dec 2004225223
Jan 2005217424
Feb 2005194937
Mar 2005133520
Apr 200543420
May 2005104223
Jun 200593125
Jul 200593923
Aug 200542625
Sep 200523518
Oct 200552720
Nov 200562112
Dec 200542216
Jan 200642417
Feb 20062278
Mar 200662720
Apr 20065148
May 20067217
Jun 200642516
Jul 200621410
Aug 200681513
Sep 200672718
Oct 200672626
Nov 200693325
Dec 2006121916
Jan 200771911
Feb 200751421
Mar 2007171613
Apr 200751511
May 200793520
Jun 200772215
Jul 20078169
Aug 200710812
Sep 200772417
Oct 20073118
Nov 200752612
Dec 20076149
Jan 200871714
Feb 200881215
Mar 200861517
Apr 2008121614
May 2008171117
Jun 200861910
Jul 2008174821
Aug 2008121710
Sep 200891510
Oct 2008151114
Nov 20088157
Dec 20089188
Jan 2009151018
Feb 20099115
Mar 2009122518
Apr 200982418
May 20095128
Jun 20096146
Jul 200910159
Aug 200982118
Sep 2009111714
Oct 2009171620
Nov 2009111014
Dec 20091635
Jan 2010767
Feb 2010311015
Mar 2010271211
Apr 201010114
May 201010910
Jun 201081511
Jul 20106169
Aug 2010132112
Sep 201073010
Oct 2010133211
Nov 201015167
Dec 201015227
Jan 201111308
Feb 20115275
Mar 2011102818
Apr 201114165
May 2011113625
Jun 2011173721
Jul 2011212022
Aug 2011123931
Sep 2011132227
Oct 2011141612
Nov 2011153116
Dec 2011102112
Jan 2012211614
Feb 2012143523
Mar 2012142814
Apr 2012152018
May 2012132823
Jun 2012162417
Jul 2012112721
Aug 2012233024
Sep 2012222613
Oct 2012202917
Nov 2012212915
Dec 2012302310
Jan 201324265
Feb 2013204016
Mar 2013232712
Apr 2013253619
May 2013152616
Jun 2013151910
Jul 2013231810
Aug 201314167
Sep 201312197
Oct 2013211017
Nov 201382216
Dec 201317218
Jan 2014201319
Feb 2014212217
Mar 2014161715
Apr 2014192211
May 2014251111
Jun 201492113
Jul 2014411424
Aug 201419139
Sep 2014131615
Oct 2014121013
Nov 2014141711
Dec 20143169
Jan 2015201414
Feb 2015131819
Mar 2015251617
Apr 2015141114
May 2015121210
Jun 201514169
Jul 2015231018
Aug 2015251315
Sep 2015151710
Oct 2015152220
Nov 2015899
Dec 201516713
Jan 2016231613
Feb 201691214
Mar 2016192023
Apr 2016171823
May 2016181326
Jun 2016181124
Jul 2016211011
Aug 2016241910
Sep 2016887
Oct 201652813
Nov 201621113
Dec 201622114
Jan 20172185
Feb 201702616
Mar 201711712
Apr 201702316
May 201744126
Jun 201721710
Jul 201742021
Aug 201772816
Sep 201712815
Oct 201703115
Nov 201703718
Dec 201722511
Jan 201803410
Feb 20180228
Mar 201803018
Apr 201812012
May 201802510
Jun 201802211
Jul 201852411
Aug 201862618
Sep 201813215
Oct 201802520
Nov 201843515
Dec 201827147
Jan 20191863
Feb 20192675
Mar 20193887
Apr 20193164
May 20192987
Jun 201919810
Jul 20193874
Aug 20193065
Sep 20191832
Oct 20192634
Nov 20193886
Dec 20195686
Jan 202063128
Feb 20202442
Mar 20203684
Apr 20204899
May 202031117
Jun 20203346
Jul 202033109
Aug 202021104
Sep 2020301812
Oct 20204774
Nov 2020741612
Dec 202044125
Jan 20213183

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (11)
Drug Metabolism and Disposition
Vol. 31, Issue 11
1 Nov 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES

Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
Drug Metabolism and Disposition November 1, 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES

Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
Drug Metabolism and Disposition November 1, 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics